Bionano Genomics Inc (BNGO)
1.135
+0.02
(+2.25%)
USD |
NASDAQ |
May 17, 16:00
1.135
0.00 (0.00%)
After-Hours: 20:00
Bionano Genomics Debt to Equity Ratio: 0.3513 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.3513 |
December 31, 2023 | 0.7259 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.041 |
Date | Value |
---|---|
December 31, 2020 | 0.4653 |
September 30, 2020 | 1.091 |
June 30, 2020 | 2.692 |
March 31, 2020 | -4.028 |
December 31, 2019 | 5.558 |
September 30, 2019 | -2.674 |
June 30, 2019 | -14.44 |
March 31, 2019 | 3.130 |
December 31, 2018 | 0.8907 |
September 30, 2018 | 0.5913 |
June 30, 2018 | -0.4065 |
March 31, 2018 | -0.3704 |
December 31, 2017 | -0.134 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-14.44
Minimum
Jun 2019
5.558
Maximum
Dec 2019
-0.5109
Average
--
Median
Jun 2021
Debt to Equity Ratio Benchmarks
Azenta Inc | 0.00 |
Harvard Bioscience Inc | 0.5175 |
Standard BioTools Inc | 0.0952 |
Akoya Biosciences Inc | 2.306 |
Singular Genomics Systems Inc | 0.0487 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 158.00M |
Total Liabilities (Quarterly) | 75.22M |
Shareholders Equity (Quarterly) | 82.77M |
Current Ratio | 1.463 |
Net Debt Paydown Yield | -9.11% |